EUVIMEDEUVIMED entdecken
Open Access

Hypertriglyceridemia as a Key Contributor to Abdominal Aortic Aneurysm Development and Rupture: Insights From Genetic and Experimental Models

Yaozhong Liu iD, Huilun Wang, Minzhi Yu, Lei Cai iD, Ying Zhao iD, Yalun Cheng, Yongjie Deng iD, Yang Zhao iD, Haocheng Lu iD, Xiaokang Wu iD, Guizhen Zhao, Chao Xue iD und 10 weitere

Circulation · 2025

DOI: 10.1161/circulationaha.125.074737 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, 2025. Verfasst von Yaozhong Liu und 21 weiteren Autor:innen. Beteiligte Einrichtung: Frankel Cardiovascular Center, Department of Internal Medicine (Y.L., H.W., Ying Zhao, Y.C., Y.D., Yang Zhao, X.W., G.Z., C.X., H. Liu, I.S., L.C., J…. Hauptthemen laut MEDLINE: Aortic Aneurysm, Abdominal, Hypertriglyceridemia, Aortic Rupture. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Abdominal aortic aneurysm (AAA) is a life-threatening vascular disease with no effective pharmacological treatments. The causal role of triglycerides (TGs) in AAA development remains unclear and controversial. METHODS: Mendelian randomization was applied to assess causal relationships between lipoproteins, circulating proteins, metabolites, and the risk of AAA. To test the hypothesis that elevated plasma TG levels accelerate AAA development, we used Lpl -deficient, Apoa5 -deficient, and human APOC3 transgenic mice, which display varying degrees of hypertriglyceridemia. Mechanistic studies were performed using RNA sequencing and Western blot analysis of palmitate-treated vascular smooth muscle cells and validated in vivo by local overexpression of key mediator in the suprarenal abdominal aorta. Antisense oligonucleotides targeting Angptl3 were administered to reduce TG levels and assess therapeutic potential in human APOC3 transgenic and Apoe -deficient mice. RESULTS: Mendelian randomization analyses integrating genetic, proteomic, and metabolomic data identified causal relationships between elevated TG-rich lipoproteins, TG metabolism–related proteins/metabolites, and AAA risk. In the angiotensin II infusion AAA model, most Lpl -deficient mice with severely elevated TG concentrations died of aortic rupture. Similarly, Apoa5 -deficient mice with moderately elevated TG levels developed accelerated AAA, and human APOC3 transgenic mice with dramatically elevated TG levels exhibited aortic dissection and rupture. Mechanistically, elevated TG and palmitate inhibited lysyl oxidase (LOX) maturation and reduced LOX activity. Locally overexpressing lysyl oxidase eliminated the proaneurysmal effect of hypertriglyceridemia in human APOC3 transgenic mice. Moreover, an Angptl3 -targeting antisense oligonucleotide profoundly attenuated AAA progression in both human APOC3 transgenic and Apoe -deficient mice. CONCLUSIONS: These findings identify hypertriglyceridemia as a key contributor to AAA pathogenesis and suggest that targeting TG-rich lipoproteins may be a promising therapeutic strategy for AAA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Aneurysm, AbdominalHypertriglyceridemiaAortic RuptureAnimalsApolipoprotein C-IIIHumansMiceDisease Models, AnimalMice, TransgenicLipoprotein LipaseApolipoprotein A-VTriglyceridesMaleAngiopoietin-Like Protein 3Mice, Inbred C57BLAngiopoietin-like ProteinsMice, KnockoutMice, Knockout, ApoEMendelian Randomization Analysis

Stichwörter der Autor:innen

abdominal aortic aneurysmlysyl oxidasemuscle, smooth, vascularpalmitatetriglycerides

Substanzen

Apolipoprotein C-IIILipoprotein LipaseApolipoprotein A-VTriglyceridesAngiopoietin-Like Protein 3APOC3 protein, humanApoa5 protein, mouseAngiopoietin-like ProteinsAPOA5 protein, human

Autor:innen und Institutionen

  • Frankel Cardiovascular Center, Department of Internal Medicine (Y.L., H.W., Ying Zhao, Y.C., Y.D., Yang Zhao, X.W., G.Z., C.X., H. Liu, I.S., L.C., J.Z., Y.E.C., Y.G.), University of Michigan Medical Center, Ann Arbor.
  • Department of Molecular Physiology and Biological Physics, University of Virginia School of Medicine, Charlottesville (H.W.).
  • Department of Pharmacology, University of Michigan, Ann Arbor (M.Y., A.S.).
  • Saha Cardiovascular Research Center and Department of Physiology, College of Medicine, University of Kentucky, Lexington (L.C., H.S.L., A.D., R.E.T.).
  • Department of Pharmacology, Southern University of Science and Technology, Guangdong, China (H. Lu).
  • College of Pharmacy Health, University of Houston, Houston, TX (G.Z.).

ORCID-Profile: Yaozhong Liu, Lei Cai, Ying Zhao, Yongjie Deng, Yang Zhao, Haocheng Lu, Xiaokang Wu, Chao Xue, Ida Surakka, Anna Schwendeman, Hong S Lu, Alan Daugherty, Lin Chang, Jifeng Zhang, Y Eugene Chen, Yanhong Guo

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Liu, Y., Wang, H., Yu, M., Cai, L., Zhao, Y., Cheng, Y., Deng, Y., Zhao, Y., Lu, H., Wu, X., Zhao, G., Xue, C., Liu, H., Surakka, I., Schwendeman, A., Lu, H. S., Daugherty, A., Chang, L., Zhang, J., …, & Guo, Y. (2025). Hypertriglyceridemia as a Key Contributor to Abdominal Aortic Aneurysm Development and Rupture: Insights From Genetic and Experimental Models. Circulation. https://doi.org/10.1161/circulationaha.125.074737

Vancouver

Liu Y, Wang H, Yu M, Cai L, Zhao Y, Cheng Y, et al. Hypertriglyceridemia as a Key Contributor to Abdominal Aortic Aneurysm Development and Rupture: Insights From Genetic and Experimental Models. Circulation. 2025. doi:10.1161/circulationaha.125.074737

BibTeX
@article{Liu2025,
  author = {Liu, Yaozhong and Wang, Huilun and Yu, Minzhi and Cai, Lei and Zhao, Ying and Cheng, Yalun and Deng, Yongjie and Zhao, Yang and Lu, Haocheng and Wu, Xiaokang and Zhao, Guizhen and Xue, Chao and Liu, Hongyu and Surakka, Ida and Schwendeman, Anna and Lu, Hong S and Daugherty, Alan and Chang, Lin and Zhang, Jifeng and Temel, Ryan E and Chen, Y Eugene and Guo, Yanhong},
  title = {Hypertriglyceridemia as a Key Contributor to Abdominal Aortic Aneurysm Development and Rupture: Insights From Genetic and Experimental Models},
  journal = {Circulation},
  year = {2025},
  doi = {10.1161/circulationaha.125.074737}
}
Kostenlos starten →